577 related articles for article (PubMed ID: 25788518)
1. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.
Anastasaki C; Woo AS; Messiaen LM; Gutmann DH
Hum Mol Genet; 2015 Jun; 24(12):3518-28. PubMed ID: 25788518
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.
Brown JA; Diggs-Andrews KA; Gianino SM; Gutmann DH
Mol Cell Neurosci; 2012 Jan; 49(1):13-22. PubMed ID: 21903164
[TBL] [Abstract][Full Text] [Related]
3. Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.
Brown JA; Emnett RJ; White CR; Yuede CM; Conyers SB; O'Malley KL; Wozniak DF; Gutmann DH
Hum Mol Genet; 2010 Nov; 19(22):4515-28. PubMed ID: 20826448
[TBL] [Abstract][Full Text] [Related]
4. Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.
Deraredj Nadim W; Chaumont-Dubel S; Madouri F; Cobret L; De Tauzia ML; Zajdel P; Bénédetti H; Marin P; Morisset-Lopez S
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12310-12315. PubMed ID: 27791021
[TBL] [Abstract][Full Text] [Related]
5. Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.
Anastasaki C; Gutmann DH
Hum Mol Genet; 2014 Dec; 23(25):6712-21. PubMed ID: 25070947
[TBL] [Abstract][Full Text] [Related]
6. Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
Diggs-Andrews KA; Brown JA; Gianino SM; Rubin JB; Wozniak DF; Gutmann DH
Ann Neurol; 2014 Feb; 75(2):309-16. PubMed ID: 24375753
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice.
Nguyen HT; Hinman MN; Guo X; Sharma A; Arakawa H; Luo G; Lou H
Hum Mol Genet; 2017 Oct; 26(19):3797-3807. PubMed ID: 28934393
[TBL] [Abstract][Full Text] [Related]
8. [Neurofibromin - protein structure and cellular functions in the context of neurofibromatosis type I pathogenesis].
Abramowicz A; Gos M
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1331-48. PubMed ID: 26671924
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis 1: closing the GAP between mice and men.
Dasgupta B; Gutmann DH
Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
[TBL] [Abstract][Full Text] [Related]
10. Restoring functional neurofibromin by protein transduction.
Mellert K; Lechner S; Lüdeke M; Lamla M; Möller P; Kemkemer R; Scheffzek K; Kaufmann D
Sci Rep; 2018 Apr; 8(1):6171. PubMed ID: 29670214
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis type 1 in two siblings due to maternal germline mosaicism.
Trevisson E; Forzan M; Salviati L; Clementi M
Clin Genet; 2014 Apr; 85(4):386-9. PubMed ID: 23621909
[TBL] [Abstract][Full Text] [Related]
12. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.
Dasgupta B; Dugan LL; Gutmann DH
J Neurosci; 2003 Oct; 23(26):8949-54. PubMed ID: 14523097
[TBL] [Abstract][Full Text] [Related]
13. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
14. Legius syndrome, an Update. Molecular pathology of mutations in SPRED1.
Brems H; Legius E
Keio J Med; 2013; 62(4):107-12. PubMed ID: 24334617
[TBL] [Abstract][Full Text] [Related]
15. NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.
Toonen JA; Anastasaki C; Smithson LJ; Gianino SM; Li K; Kesterson RA; Gutmann DH
Hum Mol Genet; 2016 May; 25(9):1703-13. PubMed ID: 26908603
[TBL] [Abstract][Full Text] [Related]
16. Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.
Diggs-Andrews KA; Tokuda K; Izumi Y; Zorumski CF; Wozniak DF; Gutmann DH
Ann Neurol; 2013 Feb; 73(2):309-15. PubMed ID: 23225063
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cAMP and ras signaling pathways improves distinct behavioral deficits in a zebrafish model of neurofibromatosis type 1.
Wolman MA; de Groh ED; McBride SM; Jongens TA; Granato M; Epstein JA
Cell Rep; 2014 Sep; 8(5):1265-70. PubMed ID: 25176649
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.
Patrakitkomjorn S; Kobayashi D; Morikawa T; Wilson MM; Tsubota N; Irie A; Ozawa T; Aoki M; Arimura N; Kaibuchi K; Saya H; Araki N
J Biol Chem; 2008 Apr; 283(14):9399-413. PubMed ID: 18218617
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.
Kuhrt LD; Motta E; Elmadany N; Weidling H; Fritsche-Guenther R; Efe IE; Cobb O; Chatterjee J; Boggs LG; Schnauß M; Diecke S; Semtner M; Anastasaki C; Gutmann DH; Kettenmann H
Dis Model Mech; 2023 Dec; 16(12):. PubMed ID: 37990867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]